CHRISTINA ALSOP: Open Payments
NPI 1013263003 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$188 in 7 payments from 6 companies in 2025. Trend: 2023 $81 · 2024 $443 · 2025 $188
Food & beverage: $188
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 2 | $59 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| Incyte Corporation | 1 | $28 |
| Kite Pharma, Inc. | 1 | $27 |
| TerSera Therapeutics LLC | 1 | $25 |
| Astellas Pharma US Inc | 1 | $21 |
Products named: Enhertu, MONJUVI, Yescarta, Zoladex, Xtandi.
Industry payments across NV — which companies pay providers there.
